ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder

被引：15
|
作者：
Marino, Ryan [1 ]
Perrone, Jeanmarie [2 ]
Nelson, Lewis S. [3 ]
Wiegand, Timothy J. [4 ]
Schwarz, Evan S. [5 ]
Wax, Paul M. [6 ]
Stolbach, Andrew I. [7 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Rutgers New Jersey Med Sch, Newark, NJ USA
[4] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[5] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA
[6] Univ Texas Southwestern, Dallas, TX USA
[7] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF MEDICAL TOXICOLOGY | 2019年 / 15卷 / 04期
关键词：
Buprenorphine; Waiver; X-waiver; Opioid use disorder; Opioid agonist therapy; METHADONE; DEATHS;
D O I：
10.1007/s13181-019-00728-9
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
[No abstract available]
引用
收藏
页码：307 / 309
页数：3
相关论文
共 50 条
  • [41] Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder
    Jones, Christopher M.
    McCance-Katz, Elinore F.
    [J]. ADDICTION, 2019, 114 (03) : 471 - 482
  • [42] Evaluation of Resident Physicians' Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder
    Shuey, Bryant
    Lee, Dasom
    Ugalde, Israel
    Borgan, Saif
    Bresnan, Caroline
    Qureshi, Marvi
    Mhaskar, Rahul
    Oxner, Asa
    [J]. JOURNAL OF ADDICTION MEDICINE, 2021, 15 (03) : 219 - 225
  • [43] Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings
    Speight, Chandra
    Caiola, Courtney
    Tyndall, Deborah E.
    Scott, Elaine S.
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2023, 35 (02) : 112 - 121
  • [44] CAEP Position Statement: Emergency department management of people with opioid use disorder
    Koh, Justin J.
    Klaiman, Michelle
    Miles, Isabelle
    Cook, Jolene
    Kumar, Thara
    Sheikh, Hasan
    Dong, Kathryn
    Orkin, Aaron M.
    Ali, Samina
    Shouldice, Elizabeth
    [J]. CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2020, 22 (06) : 768 - 771
  • [45] BUPRENORPHINE WAIVER TRAINING: PREPARING CHILD PSYCHIATRISTS TO TREAT OPIOID USE DISORDERS
    Yule, Amy
    Friedman, Catherine
    Jackson, Peter R.
    Josic, Tatjana
    Subramaniam, Geetha
    Deister, Diana
    Glaser, Paul E. A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S343 - S344
  • [46] ACMT Position Statement: Limiting Harms of Vaping and E-cigarette Use
    Mazer-Amirshahi, Maryann
    Garlich, Fiona M.
    Calello, Diane P.
    Stolbach, Andrew, I
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2021, 17 (01) : 87 - 90
  • [47] The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
    Joao P. De Aquino
    Suprit Parida
    Mehmet Sofuoglu
    [J]. Clinical Drug Investigation, 2021, 41 : 425 - 436
  • [48] The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
    De Aquino, Joao P.
    Parida, Suprit
    Sofuoglu, Mehmet
    [J]. CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 425 - 436
  • [49] Evaluating Changes in Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder Before and During the COVID-19 Pandemic
    Nguyen, Anh
    Binswanger, Ingrid
    Narwaney, Komal
    Xu, Stanley
    McClure, David
    Rinehart, Deborah
    Glanz, Jason
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [50] Buprenorphine Treatment for Opioid Use Disorder: An Overview
    Matisyahu Shulman
    Jonathan M. Wai
    Edward V. Nunes
    [J]. CNS Drugs, 2019, 33 : 567 - 580
12345